Search results
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe European Commission (EC) has granted Bristol Myers Squibb (BMS) approval for its Opdivo...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
Motley Fool via Yahoo Finance· 2 days agoSearching for investments that can outperform the benchmark S&P 500 index often gets wickedly...
Fork Cancer fundraiser to bring delicious food, live music to Lunken Airport
The Enquirer via Yahoo News· 1 day agoPartying for a good cause? Fork yeah! Fork Cancer, an inaugural event presented by global biopharmaceutical company Bristol Myers Squibb, is seeking to raise awareness and support for the American ...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 6 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biopharmaceutical company have returned -9%, compared to the Zacks S&P 500 ...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters· 3 days ago, opens new tab immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer...
The 5 Stocks Defining 'The Year Of The Dividend' In 2024
Benzinga via Yahoo Finance· 2 days agoReinvested stock dividends have significantly influenced the total return of the S&P 500 since 1927....
BMS stakes $80m on Prothena’s neurodegenerative candidate
Pharmaceutical Technology via Yahoo Finance· 7 days agoFive months after being cleared for clinical trials, the global licence for Prothena’s...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June | The Motley Fool
The Motley Fool· 2 days agoSearching for investments that can outperform the benchmark S&P 500 index often gets wickedly...
2024 is being called ‘the year of the dividend.’ These 5 stocks keep on giving.
MarketWatch via Yahoo Finance· 4 days agoGetty Images/iStockphoto - Stock dividends are anything but boring — they’re responsible for 36% of...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters via Yahoo News· 3 days agoThe study of 423 patients with stage 3 melanoma found that 83.7% of patients who received the...